Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
99,605,545
-
Number of holders
-
410
-
Total 13F shares, excl. options
-
95,118,085
-
Shares change
-
+5,613,666
-
Total reported value, excl. options
-
$9,245,217,222
-
Value change
-
+$547,907,714
-
Put/Call ratio
-
84%
-
Number of buys
-
226
-
Number of sells
-
-181
-
Price
-
$97.25
Significant Holders of NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) as of Q1 2021
497 filings reported holding NBIX - NEUROCRINE BIOSCIENCES INC - Common Stock as of Q1 2021.
NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) has 410 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 95,118,085 shares
of 99,605,545 outstanding shares and own 95.49% of the company stock.
Largest 10 shareholders include BlackRock Inc. (10,989,474 shares), JANUS HENDERSON GROUP PLC (9,231,289 shares), VANGUARD GROUP INC (8,829,275 shares), FMR LLC (7,102,088 shares), PRICE T ROWE ASSOCIATES INC /MD/ (5,773,359 shares), Bellevue Group AG (3,274,551 shares), STATE STREET CORP (3,267,343 shares), Bank of New York Mellon Corp (1,932,146 shares), Capital International Investors (1,572,326 shares), and PICTET ASSET MANAGEMENT LTD (1,562,523 shares).
This table shows the top 410 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.